Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity
Guangchuan Wang(Yale University), Sidi Chen(Yale Cancer Center), Xiaoyun Dai(Yale Cancer Center), Lvyun Zhu(Yale Cancer Center), Lupeng Ye(Nanjing Tech University), Ryan D. Chow(Yale Cancer Center), Charles S. Fuchs(University of Southern California), Zhigang Bai(Capital Medical University), Jonathan J. Park(Northwestern University), Matthew B. Dong(Yale University), Hanghui Ye(Yale University), Xiaoya Zhang(University of Wisconsin–Madison), Youssef Errami(Yale Cancer Center), Li Shen(University of California, Los Angeles), Paul Renauer(Yale Cancer Center)
Cited by 121
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
|JAMA Oncology|2018|1.8k
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
|New England Journal of Medicine|2013|1.5k